COMPLEMENT-DEPENDENT CYTO-TOXICITY OF ANTI-HUMAN OSTEOGENIC-SARCOMA MONOCLONAL-ANTIBODIES

被引：7

作者：

PRICE, MR

PIMM, MV

BALDWIN, RW

机构：

来源：

BRITISH JOURNAL OF CANCER | 1982年 / 46卷 / 04期

关键词：

D O I：

10.1038/bjc.1982.244

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：601 / 610

页数：10

相关论文

共 19 条

[1] BALDWIN RW, 1981, MOL ASPECTS MED, V4, P329
[2] MOUSE LEUKEMIA - THERAPY WITH MONOCLONAL-ANTIBODIES AGAINST A THYMUS DIFFERENTIATION ANTIGEN
BERNSTEIN, ID
TAM, MR
NOWINSKI, RC
[J]. SCIENCE, 1980, 207 (4426) : 68 - 71
[3] NATURAL ANTI-TUMOR SERUM REACTIVITY IN BALB-C MICE .2. CONTROL BY REGULATOR T-CELLS
COLNAGHI, MI
MENARD, S
DELLAPORTA, G
[J]. INTERNATIONAL JOURNAL OF CANCER, 1977, 19 (02) : 275 - 280
[4] PASSIVE ADMINISTRATION OF ANTISERUM AND COMPLEMENT IN PRODUCING ANTI-EL4 CYTOTOXIC ACTIVITY IN SERUM OF C57BL/6 MICE
DRAKE, WP
UNGARO, PC
MARDINEY, MR
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1973, 50 (04) : 909 - 914
[5] EMBLETON, 1981, BRIT J CANCER, V43, P582
[6] EMBLETON MJ, 1981, TRANSPLANT P, V13, P1966
[7] HELLSTROM I, 1981, J IMMUNOL, V127, P157
[8] MONOCLONAL ANTI-COLON CARCINOMA ANTIBODIES IN COMPLEMENT-DEPENDENT CYTO-TOXICITY
HERLYN, DM
KOPROWSKI, H
[J]. INTERNATIONAL JOURNAL OF CANCER, 1981, 27 (06) : 769 - 774
[9] HERLYN DM, 1980, CANCER RES, V40, P717
[10] HUDSON L, 1980, PRACTICAL IMMUNOLOGY, P347